Patent · US Active

Bifidobacterium longum

US9771624B2 · kind B2 · utility

16Cited by

1References

9Claims

0Family size

Assignee

The Procter & Gamble Company · US

Inventors

Douwe Van Sinderen · Carrigrohane, IE
Jun Xu · Mason, US
Wenzhu Zhao · Mason, US
Raymond A. Grant · Lancaster, US
Song Yuli · Mason, US
Charles Carson Bascom · Monroe, US
Duane Larry Charbonneau · Mason, US
Liam O'Mahony · Cork, IE

Key dates

Filing date	Nov 11, 2009
Grant date	Sep 26, 2017
Priority date	—
Expiry date	Nov 11, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12R2001/01
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The multiple embodiments described herein comprise the genome of a probiotic Bifidobacterium longum bifidobacteria strain and genes encoded by the genome. Various novel Bifidobacterium longum are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.